Altimmune, Inc. (ALT) Form 10-K Annual Reports
Altimmune, Inc. (ALT) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ALT
CIK: 1326190
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerAnne Kroon
Audit LocationIselin, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-05 | 2026-10-01 | 4 Filing | 0001802615-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-10-05 | 2026-10-01 | 4 Filing | 0001251779-26-000011 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | 4 Filing | 0002156820-26-000004 | View SEC Doc Filr Page |
| 3 | 2026-10-02 | 2026-10-01 | 3 Filing | 0002156820-26-000003 | View SEC Doc Filr Page |
| 8-K | 2026-09-29 | 2026-09-24 | 8-K | 0001326190-26-000056 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-16 | 4 Filing | 0001595064-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-13 | 4 Filing | 0001698665-26-000007 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001326190-26-000052 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | 8-K | 0001326190-26-000049 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-07-31 | 4 Filing | 0001251779-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-07-31 | 4 Filing | 0001705905-26-000010 | View SEC Doc Filr Page |
| 8-K | 2026-07-28 | 2026-07-28 | 8-K | 0001326190-26-000044 | View SEC Doc Filr Page |
| 8-K | 2026-06-16 | 2026-06-16 | FORM 8-K | 0001104659-26-074575 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001214659-26-006495 | View SEC Doc Filr Page |
| S-8 | 2026-05-13 | — | S-8 | 0001326190-26-000041 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | 10-Q | 0001326190-26-000040 | View SEC Doc Filr Page |
| 8-K | 2026-05-13 | 2026-05-13 | 8-K | 0001326190-26-000037 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-12 | — | SCHEDULE 13G Filing | 0000093751-26-000201 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-01 | — | SCHEDULE 13G Filing | 0000905148-26-002008 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-01 | — | SCHEDULE 13G Filing | 0001193125-26-201587 | View SEC Doc Filr Page |
| 4 | 2026-05-01 | 2026-05-01 | 4 Filing | 0001960596-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-01 | 2026-05-01 | 4 Filing | 0001555132-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-05-01 | 2026-05-01 | 4 Filing | 0001527204-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-01 | 2026-05-01 | 4 Filing | 0001705904-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-01 | 2026-05-01 | 4 Filing | 0001743611-26-000004 | View SEC Doc Filr Page |